D-Wave Quantum: The 200-Day Line Becomes the Battleground After a Chip-Driven Sell-Off and a Revenue Shock

D-Wave shares fell 13% to €20.71, one cent above its 200-day moving average, amid a sector-wide tech rout triggered by Broadcom's AI disappointment and strong jobs data, despite being up 168% year-to-date.

D-Wave Quantum shares closed Friday at exactly €20.71, a 13% plunge that parked the stock just one cent above its 200-day moving average of €20.70. For chart watchers, this is the line in the sand. A decisive break below would signal a bearish shift in long-term momentum, an ominous prospect for a stock that has already surrendered nearly 20% of its value over the past seven trading sessions.

The rout was not triggered by company-specific news. Instead, it was part of a sector-wide exodus from speculative technology names. The Philadelphia Semiconductor Index tumbled 8.5% after Broadcom disappointed the market with an AI revenue forecast that failed to meet the most aggressive expectations. Nvidia fell 6%, AMD lost 10.5%, and the selling pressure cascaded into quantum computing names like D-Wave. Strong US employment data added to the damage by fueling fears that interest rates will stay higher for longer — a particularly hostile environment for high-growth, pre-profit companies.

Despite the brutal week, D-Wave's year-to-date performance remains strong. The stock is still up roughly 168% in 2025, and on a twelve-month basis it has gained about 44%. That prior run-up had made profit-taking almost inevitable, and Friday's move shows just how quickly momentum can reverse in a stock with annualized volatility near 138%.

Fundamental picture offers mixed signals

The operational narrative, however, is not all bleak. D-Wave is pushing ahead with its "dual-platform" strategy, combining annealing and gate-model quantum computing following the acquisition of Quantum Circuits Inc. Management recently laid out a technical roadmap targeting 100 logical qubits by 2032, a bold ambition that underscores the company's long-term positioning.

Order flow has also provided some support. The company announced a cloud deal worth $10 million with a Fortune-100 client, and total new contracts have reached $30 million — including a $20 million award from Florida Atlantic University. These wins signal real commercial traction, even as the financial statements tell a sobering near-term story.

First-quarter revenue came in at just $2.9 million, an 81% decline from the prior-year period. The comparison is distorted by one-time revenue items in the year-ago quarter, but the net loss of $18.4 million nonetheless highlights how far the company is from operating self-sufficiency.

Government cash and a rival's IPO provide context

The US Department of Commerce injected $100 million in equity into D-Wave under the CHIPS Act, a vote of confidence that gives the balance sheet some breathing room. Meanwhile, policy momentum may be building: discussions at the Tennessee Valley Corridor National Summit touched on possible expansions of the National Quantum Initiative Act, which could unlock more federal procurement and funding for quantum hardware players. No concrete legislation has emerged yet, but the direction of travel is positive.

Perhaps the most telling signal of long-term investor appetite came from Quantinuum, which raised $1.68 billion in an IPO on June 3 that was 20 times oversubscribed. Institutional capital is flowing into the quantum sector, even if public market participants are currently skittish about macro headlines.

Technical crossroads ahead

The Relative Strength Index currently sits near 48, suggesting the stock is neither overbought nor oversold — leaving room for further downside or a bounce. Management will have a chance to reset the narrative at the Rosenblatt Technology Summit on Wednesday, where investor presentations often provide short-term catalysts. Analysts have a consensus price target of $36.44, implying significant upside from current levels. But first, the stock must defend the 200-day moving average. If it fails, the recovery could take far longer than the 44% twelve-month gain suggests.